Introduction
Adequate placental function is essential for an uncomplicated pregnancy and optimal fetal development as the placenta enables fetal nutrient supply, respiratory gas exchange and elimination of metabolic waste products (Carter, 2012; Guttmacher et al., 2014) . Furthermore, the placenta produces hormones that are crucial for maintaining pregnancy including hCG, estrogen, progesterone and prostaglandins (Fowden et al., 2015) . A suboptimal placental function is associated with pregnancy complications, including preeclampsia (which, in turn, further deteriorates placental hemodynamics and impairs fetal blood supply), fetal growth restriction and premature delivery, which are major causes of maternal and perinatal morbidity and mortality worldwide (Kovo et al., 2011; Bilano et al., 2014; Odibo et al., 2014; Vinnars et al., 2015) .
Thyroid hormone (TH) transporters and receptors are expressed in the trophoblast cells (Barber et al., 2005; Loubiere et al., 2010; Aghajanova et al., 2011; Patel et al., 2011) and optimal TH concentrations are necessary to ensure appropriate placentation (Krassas et al., 2010) . Placentation is a complex process that requires proper interstitial invasion of fetal trophoblast cells into maternal decidua and endovascular trophoblast (EVT) invasion into maternal spiral arteries (Cartwright et al., 2010) . This is, in part, regulated by pro-and antiangiogenic factors and cytokines (Cartwright et al., 2010) . TH regulates secretion of several growth factors and cytokines that are critical for EVT invasion and angiogenesis of maternal and fetal placental vessels, including angiogenin, angiopoietin 2 (Ang-2), vascular endothelial growth factor-A (VEGF-A), interleukin 10 (IL-10) and tumor necrosis factor alpha (TNF-α) (Vasilopoulou et al., 2014) . Furthermore, TH attenuates epidermal growth factor (EGF)-initiated trophoblast proliferation (Barber et al., 2005) , motility (Matsuo et al., 1993) and invasion (Oki et al., 2004) .
Low thyroid function has been associated with premature delivery (Korevaar et al., 2013; Sheehan et al., 2015) and high thyroid function has been associated with preeclampsia (Aggarawal et al., 2014; Medici et al., 2014) and fetal growth restriction (Medici et al., 2013; Haddow et al., 2014) , which are adverse pregnancy outcomes that could be arising from impaired placentation in early gestation (Cartwright et al., 2010) . Given that placental tissue is responsive to TH (Barber et al., 2005; Loubiere et al., 2010; Aghajanova et al., 2011; Patel et al., 2011) , we hypothesized that early maternal thyroid function is a regulator of placentation. Despite the increasing body of basic evidence suggesting that TH plays a role in regulation of placental development, there is a lack of data that translate these findings to clinical outcomes. Moreover, as thyroid dysfunction (Korevaar et al., 2013; Medici et al., 2013 Medici et al., , 2014 and placental dysfunction (Odibo et al., 2014) are associated with the same pregnancy complications, the clinical association of thyroid function with adverse pregnancy outcomes might be mediated via changes in placental function or vice versa.
Therefore, the aim of this study was to translate and quantify experimental findings on the link between TH and placental function into a clinical context within a large prospective population-based cohort. In addition, we aimed to examine the mediating role of the placental function in the association of TH with birth weight, preeclampsia and premature delivery.
Materials and Methods

Study population
This study was embedded in The Generation R cohort, a populationbased prospective study from early fetal life onwards in Rotterdam, the Netherlands . The study was designed to identify early environmental and genetic causes leading to normal and abnormal growth, development and health during fetal life and childhood . In total, 7069 mothers with expected delivery date between April 2002 and January 2006 were enrolled during early pregnancy. Thyroidstimulating hormone (TSH) and free thyroxine (FT4) were determined in the first available serum sample during early pregnancy (<18 weeks) and were available in 6065 women, from which 5289 had available placental function measurements. Women with thyroid disease, thyroid (interfering) medication, IVF and/or twin pregnancies were excluded from the analysis (N = 76, N = 4, N = 25, respectively). The final population of women included in the analysis comprised 5184 women (Fig. 1) . Written informed consent was obtained from all participants. The general design, all research aims and the specific measurements in the Generation R study have been approved by the Medical Ethical Committee of the Erasmus Medical Center, Rotterdam.
Thyroid measurements
Maternal serum samples were obtained in early pregnancy (median 13.4 weeks, 95% range 9.7-17.6 weeks). Plain tubes were centrifuged and serum was stored at −80°C. TSH and FT4 concentrations in maternal serum samples were determined using chemiluminescence assays (Vitros ECi; Ortho Clinical Diagnostics). Maternal thyroid peroxidase antibodies (TPOAbs) were measured using the Phadia 250 immunoassay (Phadia AB) and were regarded as positive when greater than 60 IU/ml (Medici et al., 2012) . Euthyroidism was defined according to the 2.5-97.5th percentile reference range for the study population (Medici et al., 2012) .
Placental function measurements
Measurements of placental vascular resistance were used as a reflection of placental function and a proxy measure of the placentation success (Campbell et al., 1983) . Placental vascular resistance was evaluated with recorded flow-velocity waveforms from the umbilical (representing the fetal vascular compartment) and uterine (representing the maternal vascular compartment) arteries in the second trimester (median 20.5 weeks, 95% range 18.7-23.1 weeks) and third trimester (median 30.4 weeks, 95% range 28.6-32.8 weeks) (Verburg et al., 2008) , with the median time of 9.9 weeks between the two measurements. The median time intervals between blood sampling and placental hemodynamic measurements in the second trimester were 7.1 weeks and in the third trimester were 17 weeks. A raised umbilical artery pulsatility index (PI) and uterine artery resistance index (RI) indicate increased placental vascular resistance which is a sign of (subsequent) placental insufficiency, that may occur as a result of impaired placentation (Gagnon, 2003; Baschat and Hecher, 2004) . Umbilical artery PI was measured in a free-floating loop of the umbilical cord. Uterine artery RI was measured in the uterine arteries near the crossover with the external iliac artery. For each measurement, three consecutive uniform waveforms were recorded by pulsed Doppler ultrasound, during fetal apnea and without fetal movement. The mean of three measurements was used for further analysis. The presence of notching in the third trimester was assessed in the uterine arteries and reflects an abnormal waveform resulting from increased blood flow resistance, which is a sign of placental insufficiency (Li et al., 2005) . Ultrasound measurements and analyses were performed in a blinded fashion with regard to the previous measurements and pregnancy outcome.
Outcomes of pregnancy
Information on birth weight was obtained from hospital registries. Birth weight standard deviation scores adjusted for gestational age were constructed using the Niklasson percentile growth curves (Niklasson and Albertsson-Wikland, 2008) . Premature delivery was defined as a gestational age at birth <37 weeks. Gestational hypertension was defined as development of systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg after 20 weeks of gestation in previously normotensive women. These criteria plus the presence of proteinuria (defined as two or more dipstick readings of 2+ or greater, one catheter sample reading of 1+ or greater, or a 24-h urine collection containing at least 300 mg of protein) were used to identify women with preeclampsia (Brown et al., 2001) .
Covariates
Information on maternal ethnicity and smoking status was obtained by questionnaires during pregnancy. Ethnicity was determined by the country of origin and was defined according to the classification of Statistics Netherlands . Maternal smoking was classified as no smoking, smoking until known pregnancy and continued smoking during pregnancy. Information on parity and sex of the child was obtained from hospital registries. BMI was measured at inclusion in the study.
Statistical analysis
We investigated the associations of TSH and FT4 with umbilical artery PI and uterine artery RI by using multiple linear regression analyses with restricted cubic splines utilizing three knots, to account for possible nonlinear associations (Friedman, 1991) . To study the association of TSH and FT4 with the risk of notching in the uterine arteries, we used multiple logistic regression models with restricted cubic splines utilizing three knots. TSH and FT4 values were logarithmically transformed to allow for a better model fit. Multivariable associations were graphically depicted by plots and β estimates/odds ratios with 95% CIs are shown in Supplementary Tables SII and SIII. In order to properly investigate placental function as a mediator in the association of thyroid function with birth weight, we investigated the prerequisite associations: the association of thyroid function and placental function was examined in this study, the associations of thyroid function and pregnancy outcomes were examined and described previously (Korevaar et al., 2013; Medici et al., 2013 Medici et al., , 2014 as was the association of placental vascular RIs with pregnancy outcomes (Gaillard et al., 2013) . To examine the mediating role of placental function in the associations of TH with pregnancy outcomes and vice versa, we analyzed the direct and indirect causal mediation effects by performing mediation analyses using the approach of Imai et al. (2010) . All model covariates were selected based on biological plausibility based on the previous studies, change of the effect estimate of interest and/or residual variability of the model in this study. The analyses were adjusted for gestational age at blood sampling, smoking, maternal age, parity, ethnicity, BMI, fetal sex and gestational age at ultrasound measurement. We performed sensitivity analyses in order to examine whether additional adjustment to hCG, placental angiogenic factors (placental growth factor and soluble FMS-like tyrosine kinase, previously described as the determinants of thyroid function; Korevaar et al. (2015) , maternal blood pressure or presence of TPOAbs would affect the effect estimates. We also performed sensitivity analyses by selecting euthyroid women only.
We accounted for the high number of statistical tests (38 in total) by controlling the false discovery rate (Benjamini and Hochberg) using the fdrtool package (Benjamini and Hochberg, 1995; Strimmer, 2008) . This method allows for tailored identification of the expected proportion of false positive results among all rejected null hypotheses. We identified that a q-value of 0.045 (i.e. the cut-off for a 4.5% chance of having a type I error) was similar to a P-value of 0.05, therefore a P-value threshold of <0.05 was considered for statistical significance.
In the first part of the analysis, where we studied the association of TSH and FT4 with placental vascular resistance, we performed multiple imputation according to Markov Chain Monte Carlo method, for covariates with missing data (Sterne et al., 2009) . Before imputation of the missing values, we performed exploratory analyses by investigating the pattern of missingness for each variable. All variables showed random missingness patterns and the missingness was fully accounted for by complete variables rendering us to conclude the data was M(C)AR. The percentage of missing data was <1% for sex, parity, BMI and gestational age at birth variables. Furthermore, the percentage of missing data was 10.8% for smoking, 6.4% for education and 3.4% for ethnicity variables. Twenty imputed data sets were created and pooled for the analysis. Maternal smoking, education, ethnicity, parity, BMI and fetal sex were then added to the model. Furthermore, we added umbilical artery PI, uterine artery RI, uterine artery notching, maternal TSH and FT4 concentrations as prediction variables only. No statistically significant differences in descriptive statistics were found between the original and imputed data sets. For mediation subanalyses, differential missingness for data on placental hemodynamics on outcomes in data sets that were previously used to study adverse outcomes was coped with by performing multiple imputation for data on umbilical artery PI, uterine artery RI and uterine artery notching values (Crawford et al., 1995) of placental function data. Twenty imputed data sets were created and pooled for the analysis. TSH and FT4 concentration, as well as pregnancy outcomes, were used as predictor variables only and were not imputed. No statistically significant differences in descriptive statistics were found between the imputed data sets.
Statistical analyses were performed using Statistical Package of Social Sciences version 21.0 for Windows (SPSS Inc. Armonk, NY) and R statistical software version 3.2.0 (package 'rms', 'mediation' and 'fdrtool').
Results
The final study population consisted of 5184 pregnant women (Fig. 1) for which at least one placental function measurement was available. The concurrent measurements of second-and third-trimester umbilical artery PI and uterine artery RI were available for 3762 and 2062 women, respectively (Fig. 1) . Descriptive statistics of the study population are shown in Table I . As compared to women for whom the placental function measurements were available, women without Data shown after imputation of missing data, except for data on TPO antibody positivity, which was not imputed. TSH, thyroid-stimulating hormone; PI, pulsatility index; RI, resistance index; TPO, thyroid peroxidase.
placental function measurements had blood samples drawn at slightly later gestational age, had higher BMI and were of a lower educational level (Supplementary Table SI) .
The association of thyroid function with placental vascular RIs
As is shown in Fig. 2 , TSH was negatively linearly associated with umbilical artery PI (P = 0.011) but not with uterine artery RI (P = 0.78) in the second trimester. Furthermore, FT4 was positively linearly associated with umbilical artery PI (P = 0.027) and uterine artery RI (P = 0.003) in the second trimester (Fig. 2) . As Fig. 3 shows, TSH was not associated with umbilical artery PI (P = 0.18) and uterine artery RI (P = 0.75) in the third trimester. FT4 was positively linearly associated with umbilical artery PI (P = 0.015) but not with uterine artery RI (P = 0.91) in the third trimester (Fig. 3) . Figure 4 shows the association of thyroid function and the risk of uterine artery notching during the third trimester. Higher concentration of FT4 was associated with a higher risk of notching (P = 0.0001), whereas TSH was not associated with the risk of notching (P = 0.075).
Sensitivity analyses showed no change in the results after adjusting for hCG, placental angiogenic factors, maternal blood pressure and TPOAbs. All reported associations remained similar when analyzed in euthyroid women only, except for the association of FT4 with umbilical artery PI measured in the second trimester, which was not statistically significant (Supplementary Figs S1-S3) .
Placental function as a potential mediator in the association of thyroid function with adverse pregnancy outcomes
In Supplementary Table SIV, the results of mediation analysis for different outcomes (preeclampsia, birth weight and premature delivery) are shown. There was no mediation by placental function in the association of thyroid function with the risk of preeclampsia, except for second-trimester uterine artery RI (P for mediation = 0.02, the percentage of mediated effect: 10.4%). Similarly, in the association of thyroid function with birth weight, there was no mediating role of placental function except for the second-trimester uterine artery RI (P for mediation <0.01, percentage of mediated effect: 12.5%). There was no mediating role of placental function in the association of thyroid function and the risk of premature delivery. Figure 4 The association of maternal thyroid function with the risk of uterine artery notching in the third trimester Plots show the logistic regression models for TSH and FT4 and the risk of third trimester notching in the uterine artery, as predicted mean with 95% CI. Analyses were adjusted for gestational age at blood sampling, smoking, BMI, gestational age at ultrasound, maternal age, ethnicity, parity and fetal sex. Odds ratios with 95% CIs are shown in Supplementary Table SIII.
Discussion
Our data show an association of early gestational thyroid function with measures of placental vascular function in later pregnancy. To our knowledge, this is the first study that investigates the association of gestational thyroid function with the placental function in a clinical context. Higher maternal FT4 concentration during early pregnancy was associated with higher placental vascular resistance in the period of 18.7-23.1 and 28.6-32.8 weeks of gestation. Taken together, these results suggest that high thyroid function during early pregnancy may influence placental function during the second half of pregnancy, most likely through impaired placentation. Our results also suggest that 10.4% and 12.5% of the association of high thyroid function with preeclampsia and birth weight, respectively, could be occurring through changes in placental hemodynamics, respectively.
In the current study, a higher FT4 concentration was associated with higher vascular resistance in the second trimester, in both fetal and maternal compartment of the placenta. This suggests that TH affects the formation of the placenta as a whole, i.e. both feto-placental and utero-placental circulation, and that high thyroid function in early pregnancy is a risk factor for impaired placentation and vascularization. This could be explained by a combination of TH-mediated effects; first of all, TH mediates down-regulation of VEGF-A, a factor promoting maternal and fetal angiogenesis and increasing trophoblast motility (Lash et al., 1999; Wulff et al., 2003) . Secondly, TH attenuates EGFrelated actions on trophoblast motility and invasion (Barber et al., 2005) . Furthermore, TH induces down-regulation of IL-10, necessary for vascular development, and up-regulates TNF-α, which is known to inhibit EVT invasion and trophoblast proliferation (Otun et al., 2011; Vasilopoulou et al., 2014) .
Higher FT4 was associated with placental outcomes in the third trimester, namely a higher umbilical PI, as well as with a higher risk of uterine artery notching. This suggests that the effects of TH on placental development during early pregnancy may have a persistent impact on the quality of placental vessels and function in both fetal and maternal compartment. On the other hand, FT4 was not associated with third-trimester uterine artery RI (a measure of placental function on the maternal side). This may suggest that, although the placental development as a whole is affected by exposure to THs, the effects on the fetal side are more persistent, possibly due to the active placental transfer of maternal thyroxine to the fetus or due to gestational agespecific changes in the TH effects on the angiogenic factors and cytokines secretion (Vasilopoulou et al., 2014) . Alternatively, this might be explained by the second wave of EVT invasion which occurs during the second trimester (Lyall et al., 2001) . This process may remodel spiral arteries and thus improve placental angiogenesis and blood flow during later gestation, yet be differently affected by THs as compared to early trophoblast invasion.
The exact origin of impaired placentation has not been clarified completely. Placentation is a very precise process and impairment of any stage can result in pregnancy complications (Cartwright et al., 2010) . The fact that we observed similar associations also within the euthyroid subgroup of women, suggests that even 'high-normal' FT4 values might be leading to a certain impairment in the placental function.
TSH may have transient and limited effects on placentation, compared to FT4 effects. High TSH concentration was associated with lower vascular resistance in the umbilical artery during the second trimester, in line with the opposing effects of FT4 at that time point. However, there was no association of TSH with umbilical artery resistance in the third trimester, nor with uterine artery vascular resistance in second or third gestational trimester. Similarly, other gestational outcomes determined by thyroid function, such as fetal brain development and preeclampsia, are shown to be associated with FT4 concentration and not with TSH concentration (Medici et al., 2014; Korevaar et al., 2016) . Furthermore, TH production during pregnancy is considerably stimulated by hCG and the increase in FT4 subsequently causes a transient decrease in TSH concentration (Glinoer, 1999) . This might suggest that FT4 better reflects thyroid function during gestation and that the role of TSH as a unique indicator of thyroid function is potentially less pertinent during pregnancy, compared to a non-pregnant state. Together with the placental transfer of FT4 but not TSH, this could explain the stronger associations of FT4 with placental hemodynamics compared to the associations with TSH observed in this study.
Alternatively, we can speculate that the small effects of TSH we observed could be a physiological reflection of thyrotropin releasing hormone effects, which is shown to be present in substances released by placental tissue (Shambaugh et al., 1979; Youngblood et al., 1980) . Those effects might be timely regulated and pointed toward the control of the fetal hypothalamo-pituitary-thyroid axis formation occurring in early pregnancy. The potential transient nature of this phenomenon could also explain the transient associations we observed between TSH and placental function measurements.
It is known that pregnancies with overt hyperthyroidism, mostly caused by TSH receptor stimulating antibodies in the context of Graves' disease, are more likely to be complicated with both maternal and fetal morbidity, including premature delivery, placenta abruptio and fetal growth restriction (Mestman, 1997) . Furthermore, even highnormal FT4 concentration is shown to be associated with higher risk of preeclampsia (Medici et al., 2014) and fetal growth restriction (Medici et al., 2013; Haddow et al., 2014) . Our results might suggest that the effects of TH on these outcomes are partially explained by the effects of high thyroid function on the placental function. Based on the performed mediation analysis, we observed that 10.4% and 12.5% of the association of TH with preeclampsia and birth weight could be mediated via changes in placental function, respectively. However, these effects are relatively small and were not consistent across pregnancy outcomes or ultrasound measurements. This suggests that the association of TH with pregnancy outcomes is largely explained by either (i) direct effects of TH, or (ii) through effects on potential mediators other than placental function, such as effects on fetal growth and development or more generalized effects on overall metabolic state. On the one hand, this could be expected since TH responsive tissues are widespread and the range of TH effects includes the regulation of many maternal and fetal tissues. Nonetheless, the analyses in the current study should not yet overrule a potentially important role of the placenta as an influential mediator, as the methods used in this study might be insufficient to accurately examine and estimate potential effects. Further studies are needed to verify our results. Of particular interest would be to re-analyze clinical trials that have investigated the effects of levothyroxine treatment. Little is known about the effects of TH on placentation in vivo and/or in humans. To our knowledge, no study has investigated the association of gestational thyroid function with a measure of placental function in a clinical setting. In this study, we were able to observe the association of maternal thyroid status in early pregnancy with subsequent measures of placental function prospectively, in a large number of women and also at two different time points of gestation.
A potential limitation of this study is that only a single TH measurement was available and therefore we were not able to assess the association of TH changes during gestation with placental function. However, longitudinal studies in pregnant women have shown a relatively low intra-individual variation of TH during the course of gestation (Boas et al., 2009) . Another potential limitation is the different numbers of missing placental ultrasound measurements, which may have introduced bias. This was particularly the case for the mediation analyses on preeclampsia for which the missingness led to a large proportion of missing data of the outcome. However, we coped with this by imputing variables with missing data in the data sets used for mediation analyses. Finally, the observational nature of this study does not allow for inference of causality and does not preclude the existence of residual confounding.
In conclusion, our data demonstrate that high thyroid function in early pregnancy is associated with measures of placental vascular function in both the maternal and fetal compartment during the second and third trimesters. The underlying mechanism of these associations may involve TH effects on the key growth factors and cytokines included in early placentation. Further research is necessary to investigate the biological mechanism by which maternal TH affects placental function and to further translate the findings from in vitro studies into clinically relevant associations.
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